The fight against a type of pediatric cancer

Meritxell Teixidó, IRB Barcelona

Meritxell Teixidó, IRB Barcelona


The newspaper La Razón has interviewed IRB Barcelona researcher Meritxel Teixidó in the context of the grant award ceremony of the ”la Caixa” Foundation, which was held on 16 September.Teixidó has received a CaixaImpulse grant to work towards the preclinical development of one of the compounds that shows the greatest therapeutic potential for a given type of pediatric brain cancer. “We know that drugs are necessary to treat these patients, but they can´t reach the brain in sufficient amounts. Greater amounts could be administered to ensure that the correct amount reaches the brain but this would cause many side effects,” explains Teixidó, who goes on to say that, “the idea is to perform assays on mice to test whether our peptides can carry drugs into the brain in these animals”.

Link to La Razón

 

Documents: